Cargando…
Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies
Mitochondria ensure the supply of cellular energy through the production of ATP via oxidative phosphorylation. The alteration of this process, called mitochondrial dysfunction, leads to a reduction in ATP and an increase in the production of reactive oxygen species (ROS). Mitochondrial dysfunction c...
Autores principales: | Stamerra, Cosimo Andrea, Di Giosia, Paolo, Giorgini, Paolo, Ferri, Claudio, Sukhorukov, Vasily N., Sahebkar, Amirhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363184/ https://www.ncbi.nlm.nih.gov/pubmed/35958017 http://dx.doi.org/10.1155/2022/9530007 |
Ejemplares similares
-
Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021) -
Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system
por: Sahebkar, Amirhossein, et al.
Publicado: (2020) -
Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk
por: Grassi, Davide, et al.
Publicado: (2013) -
Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases
por: Blagov, Alexander V., et al.
Publicado: (2022) -
Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
por: Shi, Shuqing, et al.
Publicado: (2022)